Grande García, Carlos
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis. [carta] - Haematologica, 2014 - 99(8):e138-41.
Formato Vancouver:
Montes Moreno S, Batlle A, de Villambrosía SG, Sánchez Espiridión B, Cereceda L, González Barca E et al. Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis. Haematologica. 2014 Aug;99(8):e138-41.
PMID: 24763400
PMC4116846
Contiene 15 referencias
No abstract available
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis. [carta] - Haematologica, 2014 - 99(8):e138-41.
Formato Vancouver:
Montes Moreno S, Batlle A, de Villambrosía SG, Sánchez Espiridión B, Cereceda L, González Barca E et al. Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis. Haematologica. 2014 Aug;99(8):e138-41.
PMID: 24763400
PMC4116846
Contiene 15 referencias
No abstract available
